These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
518 related articles for article (PubMed ID: 16203774)
21. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847 [TBL] [Abstract][Full Text] [Related]
22. Genomic rearrangements in MSH2, MLH1 or MSH6 are rare in HNPCC patients carrying point mutations. Pistorius S; Görgens H; Plaschke J; Hoehl R; Krüger S; Engel C; Saeger HD; Schackert HK Cancer Lett; 2007 Apr; 248(1):89-95. PubMed ID: 16837128 [TBL] [Abstract][Full Text] [Related]
23. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis. Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426 [TBL] [Abstract][Full Text] [Related]
24. Genetic testing for hereditary nonpolyposis colorectal cancer. Hoedema R; Monroe T; Bos C; Palmer S; Kim D; Marvin M; Luchtefeld M Am Surg; 2003 May; 69(5):387-91; discussion 391-2. PubMed ID: 12769209 [TBL] [Abstract][Full Text] [Related]
25. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing. Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451 [TBL] [Abstract][Full Text] [Related]
26. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden. Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575 [TBL] [Abstract][Full Text] [Related]
27. Association of colonic and endometrial carcinomas in Portuguese families with hereditary nonpolyposis colorectal carcinoma significantly increases the probability of detecting a pathogenic mutation in mismatch repair genes, primarily the MSH2 gene. Lage PA; Albuquerque C; Sousa RG; Cravo ML; Salazar M; Francisco I; Maia L; Claro I; Suspiro A; Rodrigues P; Raposo H; Fidalgo PA; Nobre-Leitão C Cancer; 2004 Jul; 101(1):172-7. PubMed ID: 15222003 [TBL] [Abstract][Full Text] [Related]
28. Germline and somatic mutation analyses in the DNA mismatch repair gene MLH3: Evidence for somatic mutation in colorectal cancers. Lipkin SM; Wang V; Stoler DL; Anderson GR; Kirsch I; Hadley D; Lynch HT; Collins FS Hum Mutat; 2001 May; 17(5):389-96. PubMed ID: 11317354 [TBL] [Abstract][Full Text] [Related]
29. Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR. Bettstetter M; Dechant S; Ruemmele P; Grabowski M; Keller G; Holinski-Feder E; Hartmann A; Hofstaedter F; Dietmaier W Clin Cancer Res; 2007 Jun; 13(11):3221-8. PubMed ID: 17545526 [TBL] [Abstract][Full Text] [Related]
30. Genomic deletions of MSH2 and MLH1 in colorectal cancer families detected by a novel mutation detection approach. Gille JJ; Hogervorst FB; Pals G; Wijnen JT; van Schooten RJ; Dommering CJ; Meijer GA; Craanen ME; Nederlof PM; de Jong D; McElgunn CJ; Schouten JP; Menko FH Br J Cancer; 2002 Oct; 87(8):892-7. PubMed ID: 12373605 [TBL] [Abstract][Full Text] [Related]
31. Ten novel MSH2 and MLH1 germline mutations in families with HNPCC. Krüger S; Bier A; Plaschke J; Höhl R; Aust DE; Kreuz FR; Pistorius SR; Saeger HD; Rothhammer V; Al-Taie O; Schackert HK Hum Mutat; 2004 Oct; 24(4):351-2. PubMed ID: 15365996 [TBL] [Abstract][Full Text] [Related]
32. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
34. MSH2 in contrast to MLH1 and MSH6 is frequently inactivated by exonic and promoter rearrangements in hereditary nonpolyposis colorectal cancer. Charbonnier F; Olschwang S; Wang Q; Boisson C; Martin C; Buisine MP; Puisieux A; Frebourg T Cancer Res; 2002 Feb; 62(3):848-53. PubMed ID: 11830542 [TBL] [Abstract][Full Text] [Related]
35. Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. Piñol V; Castells A; Andreu M; Castellví-Bel S; Alenda C; Llor X; Xicola RM; Rodríguez-Moranta F; Payá A; Jover R; Bessa X; JAMA; 2005 Apr; 293(16):1986-94. PubMed ID: 15855432 [TBL] [Abstract][Full Text] [Related]
36. Heterozygous mutations in PMS2 cause hereditary nonpolyposis colorectal carcinoma (Lynch syndrome). Hendriks YM; Jagmohan-Changur S; van der Klift HM; Morreau H; van Puijenbroek M; Tops C; van Os T; Wagner A; Ausems MG; Gomez E; Breuning MH; Bröcker-Vriends AH; Vasen HF; Wijnen JT Gastroenterology; 2006 Feb; 130(2):312-22. PubMed ID: 16472587 [TBL] [Abstract][Full Text] [Related]
37. Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. Lindor NM; Rabe K; Petersen GM; Haile R; Casey G; Baron J; Gallinger S; Bapat B; Aronson M; Hopper J; Jass J; LeMarchand L; Grove J; Potter J; Newcomb P; Terdiman JP; Conrad P; Moslein G; Goldberg R; Ziogas A; Anton-Culver H; de Andrade M; Siegmund K; Thibodeau SN; Boardman LA; Seminara D JAMA; 2005 Apr; 293(16):1979-85. PubMed ID: 15855431 [TBL] [Abstract][Full Text] [Related]
38. Patients with an unexplained microsatellite instable tumour have a low risk of familial cancer. Overbeek LI; Kets CM; Hebeda KM; Bodmer D; van der Looij E; Willems R; Goossens M; Arts N; Brunner HG; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ Br J Cancer; 2007 May; 96(10):1605-12. PubMed ID: 17453009 [TBL] [Abstract][Full Text] [Related]